Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
Moodys
Mallinckrodt
Merck
Boehringer Ingelheim

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

Litigation Details for Plaintiff(s) v. Defendant(s) (D. Del. 2019)

See Plans and Pricing

« Back to Dashboard

Plaintiff(s) v. Defendant(s) (D. Del. 2019)

Docket   Start Trial Date Filed 2008-01-31
Court District Court, D. Delaware Date Terminated
Cause Assigned To
Jury Demand Referred To
Parties DEFENDANT(S); PLAINTIFF(S)
Patents 10,010,507; 10,039,745; 10,058,564; 10,106,548; 10,125,140; 10,143,792; 10,154,987; 10,206,939; 10,307,419; 4,138,475; 4,371,516; 4,377,584; 4,387,089; 4,389,393; 4,535,186; 4,572,909; 4,661,491; 4,681,893; 4,760,071; 4,839,177; 4,851,229; 4,879,303; 4,892,741; 4,939,130; 4,966,768; 5,128,143; 5,178,878; 5,208,225; 5,344,932; 5,422,123; 5,643,602; 5,837,284; 5,846,976; 5,859,021; 5,898,032; 5,908,850; 5,998,427; 6,013,657; 6,024,981; 6,149,940; 6,221,392; 6,254,887; 6,274,171; 6,344,215; 6,403,120; 6,419,958; 6,423,340; 6,455,574; 6,500,814; 6,696,481; 6,794,410; 6,974,590; 7,056,500; 7,229,636; 7,404,489; 7,514,444; 7,566,729; 7,635,707; 7,691,411; 7,713,938; 7,723,390; 7,767,700; 7,816,383; 7,846,961; 7,879,349; 7,888,362; 7,910,610; 8,003,111; 8,003,353; 8,008,309; 8,013,002; 8,084,475; 8,101,659; 8,147,866; 8,318,780; 8,349,840; 8,383,150; 8,420,674; 8,476,284; 8,497,277; 8,551,957; 8,592,462; 8,603,506; 8,609,701; 8,618,109; 8,648,098; 8,697,711; 8,735,403; 8,754,090; 8,754,091; 8,754,109; 8,778,947; 8,796,331; 8,877,938; 8,940,714; 8,952,015; 8,957,079; 9,079,949; 9,089,587; 9,181,257; 9,186,346; 9,233,117; 9,233,118; 9,241,946; 9,296,753; 9,388,134; 9,415,007; 9,655,843; 9,655,857; 9,669,008; 9,725,455; 9,808,442; 9,839,637; 9,889,144; 9,901,539; 9,949,998; 9,957,232; RE36,247
Link to Docket External link to docket
Biologic Drugs cited in Plaintiff(s) v. Defendant(s)

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .

Details for Plaintiff(s) v. Defendant(s) (D. Del. 2019)

Date Filed Document No. Description Snippet Link To Document
2008-07-22 115 COMPLAINT United States Patent Nos. 6,423,340 (“the ’340 patent”) and 5,643,602 (“the ’602 patent”). This Court …22/2008 Page 12 Of 23 [11] Patent Nu`mber: [45] Date of Patent: 5,643,602 Ju]. 1, 1997 [54] ORAL …240,0?8, filed May 9, 1994, now U.S. Pat. No. 5,643,602 and which is a continuation of application Ser…Document 115-2 Filed 07/22/2008 Page 13 Of 23 5,643,602 1 ORAL COMPOSITION FOR THE TREATL[ENT DF INFLAMMATORY…Document 115-2 Filed 07/22/2008 Page 14 Of 23 5,643,602 3 the 20R-epimer of [V]I[], methyl (22RS)~1occ External link to document
2008-07-22 116 COMPLAINT United States Patent Nos. 6,200,604 B 1 ("the '604 patent") and 6,974 , 590 B2 ("the…the '590 patent") under the Patent Laws of the United States, 35 U.S.C. § 100 et seq., including…604 and '590 patents under 28 U.S.C. §§ 2201 and 2202. A copy of the '604 patent is attached as… THE PATENTS IN SUIT 11. On March 13, 2001, the '604 patent, titled "…") the '604 and '590 patents (the "Listed Patents") which cover methods of using External link to document
2018-09-21 1168 prior to the expiration of U.S. Patent No. 9,957,232 (the “’232 patent”). As set forth in its… The ’232 Patent 25. U.S. Patent No. 9,957,232, entitled “… 1. This is an action for patent infringement under the patent laws of the United States, Title…forth in greater detail in the ’232 patent, the claims of the ’232 patent, incorporated by reference herein…the ’232 patent. 31. Apotex had knowledge of the claims of the ’232 patent before External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
McKesson
Medtronic
Express Scripts
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.